SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-22-010034
Filing Date
2022-04-22
Accepted
2022-04-22 17:15:16
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 xfors-34222022.htm S-3 225627
2 EX-FILING FEES ex107.htm EX-FILING FEES 24123
3 EX-5.1 ex51_04222022.htm EX-5.1 16319
4 EX-23.1 xforex231consent4222022.htm EX-23.1 2589
5 image_1.jpg GRAPHIC 297
6 image_1a.jpg GRAPHIC 8359
7 image_3a.jpg GRAPHIC 3709
  Complete submission text file 0001628280-22-010034.txt   287104
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264459 | Film No.: 22846681
SIC: 2836 Biological Products, (No Diagnostic Substances)